One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection
Catherine E. Oldenburg, ScD, MPH1,2,3; Benjamin A. Pinsky, MD, PhD4,5,6; Jessica Brogdon, MPH, TM1; Cindi Chen, MS1; Kevin Ruder, BS1; Lina Zhong, BS1; Fanice Nyatigo, BS1; Catherine A. Cook, MPH1; Armin Hinterwirth, PhD1; Elodie Lebas, RN1; Travis Redd, MD, MPH1,2; Travis C. Porco, PhD, MPH1,2,3; Thomas M. Lietman, MD1,2,3; Benjamin F. Arnold, PhD, MPH1,2; Thuy Doan, MD, PhD1,2
doi : 10.1001/jama.2021.11517
JAMA. 2021;326(6):490-498
Azithromycin has been hypothesized to have activity against SARS-CoV-2.
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group
doi : 10.1001/jama.2021.11330
JAMA. 2021;326(6):499-518
Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized for COVID-19 have variously reported benefit, no effect, and harm.
Trends in Consumption of Ultraprocessed Foods Among US Youths Aged 2-19 Years, 1999-2018
Lu Wang, PhD, MPH1; Euridice Martínez Steele, PhD2,3; Mengxi Du, MS, MPH, RD1; Jennifer L. Pomeranz, JD, MPH, RD4; Lauren E. O’Connor, PhD, MPH5; Kirsten A. Herrick, PhD, MSc5; Hanqi Luo, PhD6; Xuehong Zhang, PhD7; Dariush Mozaffarian, MD, DrPH1; Fang Fang Zhang, MD, PhD1,8
doi : 10.1001/jama.2021.10238
JAMA. 2021;326(6):519-530
The childhood obesity rate has been steadily rising among US youths during the past 2 decades. Increasing evidence links consumption of ultraprocessed foods to excessive calorie consumption and weight gain, but trends in the consumption of ultraprocessed foods among US youths have not been well characterized.
Nicotine Pouch Unit Sales in the US, 2016-2020
Kristy L. Marynak, MPP1; Xu Wang, PhD1; Mateusz Borowiecki, BS2; Yoonsang Kim, PhD2; Michael A. Tynan, BA1; Sherry Emery, PhD2; Brian A. King, MPH, PhD1
doi : 10.1001/jama.2021.10366
JAMA. 2021;326(6):566-568
Screening for Gestational Diabetes
US Preventive Services Task Force
doi : 10.1001/jama.2021.11922
JAMA. 2021;326(6):531-538
Gestational diabetes is diabetes that develops during pregnancy. Prevalence of gestational diabetes in the US has been estimated at 5.8% to 9.2%, based on traditional diagnostic criteria, although it may be higher if more inclusive criteria are used. Pregnant persons with gestational diabetes are at increased risk for maternal and fetal complications, including preeclampsia, fetal macrosomia (which can cause shoulder dystocia and birth injury), and neonatal hypoglycemia. Gestational diabetes has also been associated with an increased risk of several long-term health outcomes in pregnant persons and intermediate outcomes in their offspring.
Screening for Gestational Diabetes
Jennifer Pillay, MSc1; Lois Donovan, MD2; Samantha Guitard, MSc1; Bernadette Zakher, MD1; Michelle Gates, PhD1; Allison Gates, PhD1; Ben Vandermeer, MSc1; Christina Bougatsos, MPH3; Roger Chou, MD3; Lisa Hartling, PhD1
doi : 10.1001/jama.2021.10404
JAMA. 2021;326(6):539-562
Gestational diabetes is associated with several poor health outcomes.
Expanding Evidence for Clinical Care of Older Adults
Michael A. Steinman, MD1,2; Cynthia M. Boyd, MD, MPH3; Kenneth E. Schmader, MD4,5
doi : 10.1001/jama.2021.12134
JAMA. 2021;326(6):475-476
The Triple Aim for Payment Reform in Joint Replacement Surgery
Caroline P. Thirukumaran, MBBS, MHA, PhD1,2; Meredith B. Rosenthal, PhD3
doi : 10.1001/jama.2021.12070
JAMA. 2021;326(6):477-478
Using Updated PubMed
Pauline Kang, PhD1; Michael Kalloniatis, PhD1,2; Gordon S. Doig, PhD2,3
doi : 10.1001/jama.2021.12021
JAMA. 2021;326(6):479-480
A Pandemic of Lights
Maureen Hirthler, MD, MFA1
doi : 10.1001/jama.2021.12213
JAMA. 2021;326(6):481-482
IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19
Michael A. Matthay, MD1; Anne F. Luetkemeyer, MD2
doi : 10.1001/jama.2021.11121
JAMA. 2021;326(6):483-485
Intake of Ultraprocessed Foods Among US Youths
Katie A. Meyer, ScD1,2; Lindsey Smith Taillie, PhD1,3
doi : 10.1001/jama.2021.9845
JAMA. 2021;326(6):485-487
Screening for Gestational Diabetes
Cuilin Zhang, MD, PhD, MPH1; Patrick Catalano, MD2
doi : 10.1001/jama.2021.12190
JAMA. 2021;326(6):487-489
Management of Patients With Microhematuria
Clark Judge, MD1; Adam S. Cifu, MD1; Sarah Faris, MD1
doi : 10.1001/jama.2021.4770
JAMA. 2021;326(6):563-564
Recently Approved Alzheimer Drug Raises Questions That Might Never Be Answered
Rita Rubin, MA
doi : 10.1001/jama.2021.11558
JAMA. 2021;326(6):469-472
US Won’t Meet National Goal Without Increased HIV Testing
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.12344
JAMA. 2021;326(6):474
Rare, Life-Threating Bacterial Infections Are Investigated
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.12041
JAMA. 2021;326(6):474
COVID-19 mRNA Vaccines Blunt Breakthrough Infection Severity
Jennifer Abbasi
doi : 10.1001/jama.2021.12619
JAMA. 2021;326(6):473
Oldest Adults Need 2 mRNA Vaccine Doses to Neutralize SARS-CoV-2
Jennifer Abbasi
doi : 10.1001/jama.2021.12179
JAMA. 2021;326(6):473
Antigen Testing Every 3 Days Is Highly Sensitive for SARS-CoV-2
Jennifer Abbasi
doi : 10.1001/jama.2021.12620
JAMA. 2021;326(6):473
The Doctors Blackwell—Biography of Pioneering Women in Medicine
N. Lynn Eckhert, MD, MPH, DrPH1
doi : 10.1001/jama.2021.7493
JAMA. 2021;326(6):467-468
Screening for Gestational Diabetes
Jill Jin, MD, MPH1
doi : 10.1001/jama.2021.11187
JAMA. 2021;326(6):577
Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients
Joshua A. Bloomstone, MD, MSc1; William F. Eckhardt III, MD2
doi : 10.1001/jama.2021.8526
JAMA. 2021;326(6):568
Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients
Takahiro Masuda, MD1; Nobuyuki Nosaka, MD, PhD1; Michio Nagashima, MD, PhD1
doi : 10.1001/jama.2021.8529
JAMA. 2021;326(6):568-569
Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients—Reply
John Laffey, MD, MA1; Giacomo Bellani, MD, PhD2; Vincenzo Russotto, MD, PhD3; for the INTUBE Investigators
doi : 10.1001/jama.2021.8532
JAMA. 2021;326(6):569
Surprise Billing in Health Care
Lauren E. Miller, MD, MBA1; Roy Xiao, MD, MS1; Vinay K. Rathi, MD, MBA1
doi : 10.1001/jama.2021.8310
JAMA. 2021;326(6):569-570
Surprise Billing in Health Care
Join Y. Luh, MD1; Eric R. Hansen, DO2; Robert A. Bitonte, MD, MA, JD, LLM3
doi : 10.1001/jama.2021.8307
JAMA. 2021;326(6):570-571
Surprise Billing in Health Care—Reply
Carrie H. Colla, PhD1
doi : 10.1001/jama.2021.8313
JAMA. 2021;326(6):571
